John R. Moore

Companies

• Edgewise Therapeutics, Inc.General counsel Mar 25, 2021 to now¹
• Alpine Immune SciencesBoard member Jun 16, 2015 to Sep 14, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEdgewise Therapeutics, Inc. EWTX17,697 shares³$658.2K at $37.19Aug 12, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 12, 2026Sold 2,419 shares at $43.80 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Sold 99 shares at $44.50 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Sold 59 shares at $44.41 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Sold 2,439 shares at $43.81 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Exercised options 6,718 shares of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Exercised options 5,781 shares of Edgewise Therapeutics, Inc.³
• Aug 12, 2025Sold 2,098 shares at $13.39 of Edgewise Therapeutics, Inc.⁴
• Aug 12, 2025Exercised options 5,781 shares of Edgewise Therapeutics, Inc.⁴
• May 2, 2025Sold 1,930 shares at $16.45 of Edgewise Therapeutics, Inc.⁵
• May 1, 2025Exercised options 5,209 shares of Edgewise Therapeutics, Inc.⁵
• Sep 23, 2024Sold 20,922 shares at $27.63 of Edgewise Therapeutics, Inc.⁶
• Sep 23, 2024Exercised options 20,922 shares at $0.71 of Edgewise Therapeutics, Inc.⁶
• Sep 20, 2024Sold 50,000 shares at $28.37 of Edgewise Therapeutics, Inc.⁶
• Sep 20, 2024Exercised options 50,000 shares at $0.71 of Edgewise Therapeutics, Inc.⁶
• May 2, 2024Sold 1,956 shares at $18.91 of Edgewise Therapeutics, Inc.⁷
• May 1, 2024Exercised options 5,208 shares of Edgewise Therapeutics, Inc.⁷
• Feb 9, 2024Sold 8,029 shares at $20.01 of Edgewise Therapeutics, Inc.⁸
• Feb 9, 2024Exercised options 8,029 shares at $1.93 of Edgewise Therapeutics, Inc.⁸
• Feb 8, 2024Sold 3,813 shares at $20.01 of Edgewise Therapeutics, Inc.⁸
• Feb 8, 2024Exercised options 3,813 shares at $1.93 of Edgewise Therapeutics, Inc.⁸
• Feb 7, 2024Sold 17,993 shares at $20.00 of Edgewise Therapeutics, Inc.⁸
• Feb 7, 2024Exercised options 17,993 shares at $1.93 of Edgewise Therapeutics, Inc.⁸
• Dec 27, 2023Sold 8,497 shares at $10.50 of Edgewise Therapeutics, Inc.⁹
• May 2, 2023Sold 1,897 shares at $8.90 of Edgewise Therapeutics, Inc.¹⁰
• May 1, 2023Exercised options 5,208 shares of Edgewise Therapeutics, Inc.¹⁰